Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?

Group 1 - Amneal Pharmaceuticals (AMRX) is a notable stock in the Medical sector, currently outperforming the sector average with a year-to-date return of 3.8% compared to the sector's average return of -4.2% [4] - The Zacks Rank system rates Amneal Pharmaceuticals as 1 (Strong Buy), indicating a positive earnings outlook and improving analyst sentiment, with a consensus estimate for full-year earnings increasing by 8.7% over the past 90 days [3][4] - Amneal Pharmaceuticals is part of the Medical - Drugs industry, which has seen a decline of approximately 11.4% year-to-date, further highlighting AMRX's relative strength within its industry [6] Group 2 - Aveanna Healthcare (AVAH) is another strong performer in the Medical sector, with a year-to-date return of 2.2% and a Zacks Rank of 1 (Strong Buy), supported by a significant 37.5% increase in its consensus EPS estimate over the past three months [5] - The Medical - Outpatient and Home Healthcare industry, to which Aveanna Healthcare belongs, has performed well with a year-to-date increase of 11.8%, ranking 86 among 18 stocks in that industry [7]